Intrauterine growth restriction and placental angiogenesis

Diagnostic Pathology

Volumn 5, Issue 1, 2010, Pages

  Barut, Figen ^a   Barut, Aykut ^a   Gun, Banu D ^a   Kandemir, Nilufer O ^a   Harma, Mehmet I ^a   Harma, Muge ^a   Aktunc, Erol ^a   Ozdamar, Sukru O ^a  

^a ZONGULDAK KARAELMAS UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOGENIC PROTEIN; ENDOTHELIAL NITRIC OXIDE SYNTHASE; FIBROBLAST GROWTH FACTOR 2; NOS3 PROTEIN, HUMAN; VASCULOTROPIN A; VEGFA PROTEIN, HUMAN;

ADULT; ANGIOGENESIS; ARTICLE; CASE CONTROL STUDY; CHEMISTRY; FEMALE; GESTATIONAL AGE; HUMAN; IMMUNOHISTOCHEMISTRY; INTRAUTERINE GROWTH RETARDATION; METABOLISM; PATHOPHYSIOLOGY; PLACENTA; PREGNANCY; UPREGULATION; VASCULARIZATION;

ADULT; ANGIOGENIC PROTEINS; CASE-CONTROL STUDIES; FEMALE; FETAL GROWTH RETARDATION; FIBROBLAST GROWTH FACTOR 2; GESTATIONAL AGE; HUMANS; IMMUNOHISTOCHEMISTRY; NEOVASCULARIZATION, PHYSIOLOGIC; NITRIC OXIDE SYNTHASE TYPE III; PLACENTA; PREGNANCY; UP-REGULATION; VASCULAR ENDOTHELIAL GROWTH FACTOR A; YOUNG ADULT;

EID: 77951079827     PISSN: None     EISSN: 17461596     Source Type: Journal    
DOI: 10.1186/1746-1596-5-24     Document Type: Article

References (20)

1. Gurel D, Özer E, Altunyurt S, Guclu S, Demir N. Expression of IGR-IR and VEGF and trophoblastic proliferative activity in placentas from pregnancies complicated by IUGR. Pathol Res Pract 2003, 199:803-809. 10.1078/0344-0338-00499, 14989492.
2. Maulik D, Evans JF, Ragolia L. Fetal growth restriction: Pathogenic mechanisms. Clin Obstet Gynecol 2006, 49:219-227. 10.1097/00003081-200606000-00005, 16721102.
3. Arroyo JA, Winn VD. Vasculogenesis and angiogenesis in the IUGR placenta. Semin Perinatol 2008, 32:172-177. 10.1053/j.semperi.2008.02.006, 18482617.
4. Ahmed A, Perkins J. Angiogenesis and intrauterine growth restriction. Baillieres Best Pract Res Clin Obstet Gynaecol 2000, 14:981-998. 10.1053/beog.2000.0139, 11141345.
5. Özkan S, Vural B, Dalçi{dotless}k C, Taş A, Dalçi{dotless}k H. Placental expression of insulin-like growth factor-I, fibroblast growth factor-basic and neural cell adhesion molecule in pregnancies with small for gestational age fetuses. J Perinatol 2008, 28:468-474. 10.1038/jp.2008.27, 18432248.
6. Shiraishi S, Nakagawa K, Kinukawa N, Nakano H, Sueishi K. Immunuhistochemical localization of vascular endothelial growth factor in the human placenta. Placenta 1996, 17:111-121. 10.1016/S0143-4004(96)80004-X, 8730881.
7. Pardi G, Marconi AM, Cetin I. Pathophysiology of intrauterine growth retardation: role of the placenta. Acta Paediatr 1997, 423(Suppl):170-172.
8. Frater JL, Kay NE, Goolsby CL, Crawford SE, Dewald GW, Peterson LC. Dysregulated angiogenesis in B-chronic lymphocytic leukemia: Morphologic, immunohistochemical, and flow cytometric evidence. Diagn Pathol 2008, 3:16. 10.1186/1746-1596-3-16, 2362108, 18423023.
9. Kaufmann P, Mayhew TM, Charnock-Jones DS. Aspects of human fetoplacental vasculogenesis and angiogenesis. II. Changes during normal pregnancy. Placenta 2004, 25:114-126. 10.1016/j.placenta.2003.10.009, 14972444.
10. Lee MY, Huang JP, Chen YY, Aplin JD, Wu YH, Chen CY, Chen PC, Chen CP. Angiogenesis in differentiated placental multipotent mesenchymal stromal cells is dependent on integrin alpha5beta1. PLoS One 2009, 4:e6913. 10.1371/journal.pone.0006913, 2760707, 19847290.
11. Nakagawa Y, Fujimoto J, Tamaya T. Placental growth by the estrogen-dependent angiogenic factors, vascular endothelial growth factor and basic fibroblast growth factor, throughout gestation. Gynecol Endocrinol 2004, 19:259-266. 10.1080/09513590400016201, 15726914.
12. Helske S, Vuorela P, Carpén O, Hornig C, Weich H, Halmesmäki E. Expression of vascular endothelial growth factor receptors 1, 2 and 3 in placentas from normal and complicated pregnancies. Mol Hum Reprod 2001, 7:205-210. 10.1093/molehr/7.2.205, 11160848.
13. Hamai Y, Fujli T, Yamashita T, Kozuma S, Okai T, Taketani Y. Evidence for basic fibroblast growth factor as a crucial angiogenic growth factor, released from human trophoblasts during early gestation. Placenta 1998, 19:149-155. 10.1016/S0143-4004(98)90003-0, 9548181.
14. Myatt L, Eis ALW, Brockman DE, Greer IA, Lyall F. Endothelial nitric oxide synthase in placental villous tissue from normal, pre-eclamptic and intrauterine growth restricted pregnancies. Hum Reprod 1997, 12:167-172. 10.1093/humrep/12.1.167, 9043923.
15. Ng YS, Krilleke D, Shima DT. VEGF function in vascular pathogenesis. Exp Cell Res 2006, 312:527-537. 10.1016/j.yexcr.2005.11.008, 16330026.
16. Galan HL, Pandipati S, Filly RA. Ultrasound evaluation of fetal biometry and normal and abnormal fetal growth. Ultrasonography in obstetrics and gynecology 2008, 225-265. USA: Saunders Elsevier, Callen PW, 5.
17. Kinzler WL, Vintzileos AM. Fetal growth restriction. Curr Opin Obstet Gynecol 2008, 2:125-131.
18. Mayhew TM, Charnock-Jones DS, Kaufmann P. Aspects of human fetoplacental vasculogenesis and angiogenesis. III. Changes in complicated pregnancies. Placenta 2004, 25:127-139. 10.1016/j.placenta.2003.10.010, 14972445.
19. Benirschke K. Recent trends in chorangiomas, especially those of multiple and recurrent chorangiomas. Pediatr Dev Pathol 1999, 2:264-269. 10.1007/s100249900122, 10191350.
20. Lyall F, Young A, Boswell F, Kingdom JCP, Greer IA. Placental expression of vascular endothelial growth factor in placentae from pregnancies complicated by pre-eclampsia and intrauterine growth restriction does not support placental hypoxia at delivery. Placenta 1997, 18:269-276. 10.1016/S0143-4004(97)80061-6, 9179920.